Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
L Bouadma, CE Luyt, F Tubach, C Cracco, A Alvarez… - The Lancet, 2010 - thelancet.com
Background Reduced duration of antibiotic treatment might contain the emergence of
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
L Bouadma, CE Luyt, F Tubach, C Cracco, A Alvarez… - The Lancet, 2010 - infona.pl
Reduced duration of antibiotic treatment might contain the emergence of multidrug-resistant
bacteria in intensive care units. We aimed to establish the effectiveness of an algorithm …
bacteria in intensive care units. We aimed to establish the effectiveness of an algorithm …
[PDF][PDF] Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
L Bouadma, CE Luyt, F Tubach, C Cracco, A Alvarez… - 2010 - jvsmedicscorner.com
Background Reduced duration of antibiotic treatment might contain the emergence of
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
L Bouadma, CE Luyt, F Tubach, C Cracco, A Alvarez… - The Lancet, 2010 - Elsevier
BACKGROUND: Reduced duration of antibiotic treatment might contain the emergence of
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
L Bouadma, CE Luyt, F Tubach, C Cracco… - Lancet (London …, 2010 - europepmc.org
Background Reduced duration of antibiotic treatment might contain the emergence of
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
[PDF][PDF] Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
L Bouadma, CE Luyt, F Tubach, C Cracco, A Alvarez… - Lancet, 2010 - academia.edu
Background Reduced duration of antibiotic treatment might contain the emergence of
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
[引用][C] Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
L BOUADMA - Lancet., 2010 - cir.nii.ac.jp
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA
trial) : a multicentre randomised controlled trial | CiNii Research CiNii 国立情報学研究所 学術 …
trial) : a multicentre randomised controlled trial | CiNii Research CiNii 国立情報学研究所 学術 …
[引用][C] Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
L BOUADMA, CE LUYT, M BERNARD… - Lancet (British …, 2010 - pascal-francis.inist.fr
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA
trial): a multicentre randomised controlled trial CNRS Inist Pascal-Francis CNRS Pascal and …
trial): a multicentre randomised controlled trial CNRS Inist Pascal-Francis CNRS Pascal and …
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
L Bouadma, CE Luyt, F Tubach, C Cracco, A Alvarez… - 2010 - cabidigitallibrary.org
Background: Reduced duration of antibiotic treatment might contain the emergence of
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …
[PDF][PDF] Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
L Bouadma, CE Luyt, F Tubach, C Cracco… - …, 2010 - ubccriticalcaremedicine.ca
Background Reduced duration of antibiotic treatment might contain the emergence of
multidrug-resistant bacteria in intensive care units. We aimed to establish the eectiveness of …
multidrug-resistant bacteria in intensive care units. We aimed to establish the eectiveness of …